PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the company will make presentations at the following upcoming events.
The International Liver Congress™ 2016 (ILC 2016) – The Annual Meeting of the European Association for the Study of the Liver – Barcelona, Spain, April 13-17, 2016
